Rigid Aortic Dissection Model-Dewei

PRODUCT CENTER

Home page

Home page

undefined

undefined

+

Home page

Rigid Aortic Dissection Model

Rigid Aortic Dissection Model,1:1 scale accurately replicates the real anatomical structure, including ascending aorta, thoracic aorta, and aortic dissection.

Market price:

¥ 999

Retail price:

¥ 999

Recently added:

in total 0 items Total 0

Quantity

-

+

Inventory remaining:

100

加入购物车

Specialty:

Medical Display Models

Keywords:

aortic

dissection

model

Email: sales@deweimed.com

隐藏域元素占位

+

Rigid Aortic Dissection Model

Rigid Aortic Dissection Model,1:1 scale accurately replicates the real anatomical structure, including ascending aorta, thoracic aorta, and aortic dissection.

Category:

Medical Display Models

Keywords:

aortic

dissection

model

Technical Highlights Structure Parameters Test Report Customer Case Studies Related videos

Technical Highlights

Integrated Design

High transparency

High-Definition Touch

One-click illumination

Product Features

High Structural Fidelity

High Structural Fidelity

3D printed based on real human CT data, simulating the true anatomical structure of blood vessels.

High Material Fidelity

High Material Fidelity

Made from simulated vascular materials and 3D printed based on real human CT data.

Structure

Ascending aorta, thoracic aorta, aortic dissection

Dimension Drawing

Hard Aortic Dissection Model

Customization

Customizable with different types of lesion modules.

Accessories

Customized Packaging Box

Customized Packaging Box

Parameters

Test Report

Compliance Test Report for Vascular Model

Compliance Test Report for Vascular Model

Firction Test Report of Vascular Model

Firction Test Report of Vascular Model

Hardness Test Report of Vascular Model Material

Hardness Test Report of Vascular Model Material

Report on Acoustic Conductivity Testing of Vascular Model Materials

Report on Acoustic Conductivity Testing of Vascular Model Materials

Report on Compressive Strength Test of Vascular Model Materials

Report on Compressive Strength Test of Vascular Model Materials

Tear Resistance Test Report of Vascular Model Material

Tear Resistance Test Report of Vascular Model Material

Tensile Strength Test Report of Vascular Model Material

Tensile Strength Test Report of Vascular Model Material

Test Report on Elastic Modulus of Vascular Model Material

Test Report on Elastic Modulus of Vascular Model Material

Test Report on Electrical Conductivity of Vascular Model

Test Report on Electrical Conductivity of Vascular Model

Test Report on Thermal Conductivity of Vascular Model Materials

Test Report on Thermal Conductivity of Vascular Model Materials

Vascular Model Material Elongation Test Report

Vascular Model Material Elongation Test Report

Vascular Model Material Surface Adhesion Test Report

Vascular Model Material Surface Adhesion Test Report

Customer Case Studies

A new breakthrough in carotid plaque phantoms: Testing model lesions with custom-tailored elastic modulus.

A new breakthrough in carotid plaque phantoms: Testing model lesions with custom-tailored elastic modulus.

In the field of medical technology, even a micrometer-level error can determine the course of life. Atherosclerosis is a chronic condition that begins with lipid metabolism abnormalities, leading to inflammation within the vessel lumen, intimal necrosis, and fibrosis—ultimately resulting in plaque formation at specific sites along the arterial walls. Over decades of gradual progression, these plaques may trigger acute cardiovascular or cerebrovascular events such as stroke or myocardial infarction.

DeWei: Innovative Applications of Medical Simulation Models

DeWei: Innovative Applications of Medical Simulation Models

In today’s rapidly advancing medical technology landscape, interventional devices—now the cornerstone of modern minimally invasive treatments—are undergoing unprecedentedly rapid iterations and updates. For device manufacturers, a high-quality interventional device showroom is not just a showcase for their products; it also serves as a vital platform to demonstrate technological expertise and attract both partners and potential customers.

DeWei All-Brain Silicone Vascular Model: Technology Empowers DSA Angiography Research

DeWei All-Brain Silicone Vascular Model: Technology Empowers DSA Angiography Research

Cerebrovascular diseases significantly contribute to global mortality and long-term disability (Vaduganathan et al., 2022). In recent years, thanks to advances in medical and imaging technologies, the mortality rates associated with intracranial arterial (IA) diseases—such as intracranial artery stenosis (ICAS), middle cerebral artery occlusion (MCAO), and intracranial aneurysms—have declined (Hess, 2018).

In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the United States.

In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the United States.

In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the U.S., Derui Medical successfully completed the delivery of its next-generation bionic cerebral vascular phantom and advanced hemodynamic testing equipment. The system has received unanimous praise from both Stanford University and leading neurointerventional physicians in the U.S., addressing critical challenges encountered during cerebral vascular intervention procedures.

In June 2023, DeWei Medical successfully delivered the cardiac intervention device delivery testing system to HeartPath Medical Technology (Guangzhou) Co., Ltd.

In June 2023, DeWei Medical successfully delivered the cardiac intervention device delivery testing system to HeartPath Medical Technology (Guangzhou) Co., Ltd.

In June 2023, Dermed Medical successfully delivered the cardiac intervention device delivery testing system to Heartway Medical Technology (Guangzhou) Co., Ltd., a rising star in China's cardiac intervention device industry.

In April 2023, DeWei Medical successfully delivered the ECMO mock-up testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences.

In April 2023, DeWei Medical successfully delivered the ECMO mock-up testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences.

In April 2023, DeWei Medical successfully delivered the ECMO phantom testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences, completing China's first-ever in-vitro validation experiment for ECMO equipment—and addressing a key scientific challenge encountered during ECMO cannulation procedures.

Related News

Endoscopic Intervention Urology System Model – Customizable Simulation Silicone Intervention Model

Endoscopic Intervention Urology System Model – Customizable Simulation Silicone Intervention Model

Urinary tract stones are a common condition in urology. As early as 1901, stones were discovered in the pelvic bones of mummies from ancient Egyptian tombs. Today, they account for 6% to 10% of all urinary system disorders, and their incidence has been steadily rising in recent years, placing a significant burden on healthcare systems worldwide.

TAVR heart model precisely simulates blood flow, driving innovation in surgical techniques.

TAVR heart model precisely simulates blood flow, driving innovation in surgical techniques.

The medical understanding and treatment of aortic stenosis (AS) have evolved significantly over centuries of exploration and advancement. In the early stages, little was known about its underlying pathological mechanisms—only by the 19th century, with advances in anatomy and pathology, did scientists begin to clearly link it to abnormalities in valve structure. By the mid-20th century, the advent of echocardiography allowed doctors to more accurately assess the severity of valve narrowing and evaluate cardiac function, dramatically improving diagnostic capabilities. In terms of treatment, early approaches relied primarily on medications to alleviate symptoms, though these methods offered only limited effectiveness.

Pioneering the pulmonary artery vascular model, DeWe Shining at the "1st Western Pulmonary Vascular Science Conference"

Pioneering the pulmonary artery vascular model, DeWe Shining at the "1st Western Pulmonary Vascular Science Conference"

From June 19 to 22, 2025, the "1st Western China Pulmonary Vascular Science Conference," hosted by the Beijing Health Promotion Association and academically supported by the Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, was held grandly in Chengdu. This prestigious academic event, bringing together leading experts from home and abroad, featured the theme "Opening a New Chapter—Fusing Innovation" and focused on cutting-edge advancements in the diagnosis, treatment, and research of pulmonary vascular diseases.

DeWei Medical's intelligent blood flow platform supports innovative applications of Zhongtian Medical's neurointerventional devices.

DeWei Medical's intelligent blood flow platform supports innovative applications of Zhongtian Medical's neurointerventional devices.

At OCIN & WLNC 2025, Zhongtian Medical proudly unveiled its globally pioneering woven microguidewire "Tianzhi™" and the all-scenario thrombus aspiration catheter "Tianjiao™." DeWei Medical, a technology company specializing in intelligent medical simulation systems, leverages its seasoned core team—veterans in medical simulation innovation—to deliver cutting-edge solutions. With their innovative neurointerventional vascular models and intelligent blood flow platform, DeWei is supporting Zhongtian Medical in advancing groundbreaking applications within the field of neurointervention.

DeWei Medical attends the 11th Northwest Vascular Conference to jointly explore a new future for vascular health.

DeWei Medical attends the 11th Northwest Vascular Conference to jointly explore a new future for vascular health.

The 11th Northwest Vascular Conference and the 20th Chang'an Vascular Conference will be held in Xi'an on June 6–7, 2025. Organized by the Shaanxi Provincial Health Care Association and others, the event will be hosted by the First Affiliated Hospital of Xi'an Jiaotong University. The conference will feature in-depth discussions on vascular diseases, along with the introduction of a challenging case competition and a cloud-based teaching platform. These initiatives aim to foster academic exchange, advance consensus-building in diagnosis and treatment, and ultimately support the development of Healthy China.

Coronary Intervention Vascular Model – Minimally Invasive Interventional Device Testing

Coronary Intervention Vascular Model – Minimally Invasive Interventional Device Testing

The heart is often referred to as the body's "perpetual motion machine," and any heart-related condition should not be taken lightly. Coronary artery disease, in particular, is a fairly common cardiovascular disorder. Officially known as coronary atherosclerotic heart disease, this condition essentially occurs when the blood vessels that supply the heart—known as coronary arteries—become narrowed or blocked due to various factors. This restricts the flow of blood to the heart muscle, leading to ischemia, oxygen deprivation, or even tissue death. As a result, patients may experience symptoms like angina or, in severe cases, even sudden cardiac arrest and death.

Radial Artery Puncture Arm Model—Puncture-Resistant Silicone with Ultrasound-Visible Features

Radial Artery Puncture Arm Model—Puncture-Resistant Silicone with Ultrasound-Visible Features

In the fields of medical education and clinical skills training, radial artery puncture is one of the essential skills that healthcare professionals must master. However, performing this procedure in real clinical settings carries high risks, and patients often have limited cooperation, making it challenging to meet the demand for repeated practice. That’s where the radial artery puncture arm model comes in—offering a highly realistic structure and functionality, it provides medical practitioners with a safe and efficient platform for hands-on training.

Focusing on intelligent neurointervention, Dewei Medical's blood flow platform technology empowers the clinical application of vascular intervention robots.

Focusing on intelligent neurointervention, Dewei Medical's blood flow platform technology empowers the clinical application of vascular intervention robots.

From May 15 to 18, 2025, WLNC & OCIN 2025, along with the Annual Academic Conference of the Stroke Branch of the Shanghai Medical Association, was held in Shanghai. On the morning of May 18, the "Neurointerventional Robotics Forum" took center stage, as experts delved into how intelligent robotic technologies are revolutionizing the field of neurointervention. Notably, medical simulation models—critical for the practical application of interventional robot systems—gained significant attention. DeWe Medical’s innovative vascular simulation models provide a cutting-edge solution, offering professional support for clinical validation and realistic scenario replication of neurointerventional robots.

Flagship Full-Body Arteriovenous Intervention Vascular Model—Transparent, Elastic Silicone with Customization Options

Flagship Full-Body Arteriovenous Intervention Vascular Model—Transparent, Elastic Silicone with Customization Options

Cardiovascular health is a core component of overall human well-being, directly influencing an individual’s quality of life and life expectancy. Cardiovascular diseases—including coronary heart disease, hypertension, stroke, and others—have become the leading cause of death among China’s population. With rapid economic growth and profound changes in lifestyle, the incidence and mortality rates of cardiovascular diseases have been steadily rising, imposing a heavy health and economic burden on both society and individuals. In China, CVD ranks first among the causes of death for urban and rural residents, accounting for 48.98% of deaths in rural areas and 47.35% in urban areas in 2021. In fact, out of every 5 deaths, 2 are attributable to CVD.

In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the United States.

In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the United States.

In May 2024, at the invitation of the Neurointerventional Hemodynamics Research Group at Stanford University in the U.S., Derui Medical successfully completed the delivery of its next-generation bionic cerebral vascular phantom and advanced hemodynamic testing equipment. The system has received unanimous praise from both Stanford University and leading neurointerventional physicians in the U.S., addressing critical challenges encountered during cerebral vascular intervention procedures.

In June 2023, DeWei Medical successfully delivered the cardiac intervention device delivery testing system to HeartPath Medical Technology (Guangzhou) Co., Ltd.

In June 2023, DeWei Medical successfully delivered the cardiac intervention device delivery testing system to HeartPath Medical Technology (Guangzhou) Co., Ltd.

In June 2023, Dermed Medical successfully delivered the cardiac intervention device delivery testing system to Heartway Medical Technology (Guangzhou) Co., Ltd., a rising star in China's cardiac intervention device industry.

In April 2023, DeWei Medical successfully delivered the ECMO mock-up testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences.

In April 2023, DeWei Medical successfully delivered the ECMO mock-up testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences.

In April 2023, DeWei Medical successfully delivered the ECMO phantom testing system to the Human Pulmonary Circulation Project Team at Fuwai Hospital, Chinese Academy of Medical Sciences, completing China's first-ever in-vitro validation experiment for ECMO equipment—and addressing a key scientific challenge encountered during ECMO cannulation procedures.

In November 2022, Derui Medical successfully developed a particle/re-transmission testing system for pan-vascular interventional devices.

In November 2022, Derui Medical successfully developed a particle/re-transmission testing system for pan-vascular interventional devices.

In November 2022, DeWei Medical successfully developed a particle/re-coating testing system for pan-vascular interventional devices. This solution addresses the critical need for in-vitro particle and re-coating validation of various pan-vascular interventional tools, including drug-coated balloons, drug-eluting stents, coated catheters, and coated guidewires.

Related videos

Close

Full-Body Arteriovenous Intervention Vascular Model – Flagship Edition

Close

Highlights from the 2024 MedTec Event

Close

Guide wire

Close

Microcatheter

Request a quote

*Please keep your phone accessible—we'll reach out to you within 24 hours.

ROADSHOW

Roadshow

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Customer Case Studies

Contact us

Phone: +86 17309181742

Email: sales@deweimed.com

Address: Wangzuo Qujiang, 3269 Yanxiang Road, Yanta District, Xi'an City

Official Account

Pre-sales Consultation

Leave a Message Online

Copyright © 2025 Xi'an Dewei Medical Technology Co., Ltd. All rights reserved.

小红书

Tel：8618192027578

Email：sales@deweimed.com

WhatsApp：8618182634037